Detection of aberrant signaling pathways in CD34+cells from patients with myelofibrosis with myeloid metaplasia using oligonulceotide microarrays.

被引：0
|
作者：
Jones, LC
Tefferi, A
Wachsman, W
Hofmann, WK
Koeffler, HP
机构：
[1] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Cedars Sinai Res Inst, Los Angeles, CA 90024 USA
[2] Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, Rochester, MN 55905 USA
[3] VASDHS, Res Serv, La Jolla, CA USA
[4] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2620
引用
收藏
页码：626A / 626A
页数：1
相关论文
共 50 条
  • [1] Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays
    Jones, LC
    Tefferi, A
    Vuong, PT
    Desmond, JC
    Hofmann, WK
    Koeffler, HP
    STEM CELLS, 2005, 23 (05) : 631 - 637
  • [2] Marrow Fibrosis Does Not Account for Circulating CD34+Cells in Myelofibrosis with Myeloid Metaplasia
    Samuelson, Scott J.
    Prchal, Josef T.
    HAEMATOLOGICA, 2007, 92 (04) : 47 - 47
  • [3] The expression of CXCR4 is down-regulated on the CD34+cells of patients with myelofibrosis with myeloid metaplasia
    Rosti, Vittorio
    Massa, Margherita
    Vannucchi, Alessandro M.
    Bergamaschi, Gaetano
    Campanelli, Rita
    Pecci, Alessandro
    Viarengo, Glanluca
    Meli, Valentina
    Marchetti, Monia
    Guglielmelli, Paola
    Bruno, Edward
    Xu, Mingjiang
    Hoffman, Ronald
    Barosi, Giovanni
    BLOOD CELLS MOLECULES AND DISEASES, 2007, 38 (03) : 280 - 286
  • [4] Reduced CD26 dipeptidylpeptidase IV membrane expression and activity of CD34+cells from patients with myelofibrosis with myeloid metaplasia.
    Campanelli, Rita
    Massa, Margherita
    Rosti, Vittorio
    Bergamaschi, Gaetano
    Viarengo, Gianluca
    Marchetti, Monia
    Hoffman, Ronald
    Barosi, Giovanni
    BLOOD, 2006, 108 (11) : 1033A - 1033A
  • [5] Myeloid metaplasia with myelofibrosis: Cytogenetic and FISH demonstration that CD34+cells but not fibroblasts belong to the pathological clone.
    Bilhou-Nabera, C
    Brigaudeau, C
    Clay, D
    Lai, JL
    Brouty-Boye, D
    Vignon, C
    Gharbi, MJ
    Le Bousse-Kerdiles, MC
    Praloran, V
    BLOOD, 2002, 100 (11) : 589A - 589A
  • [6] Effects of Imetelstat on CD34+Cells of Patients with Myelofibrosis
    Wang, Xiaoli
    Hu, Cing Siang
    Li, Yan
    Qiu, Jiajing
    Lam, Morgan
    Eng, Kevin
    Hoffman, Ronald
    BLOOD, 2014, 124 (21)
  • [7] Low number of circulating CD34+cells identifies a group of patients with myelofibrosis with myeloid metaplasia (MMM) who efficiently responds to STI571.
    Piaggio, G
    Castello, S
    Podesta, M
    Pozzi, S
    Pitto, A
    Rosti, V
    Rossi, E
    Bacigalupo, A
    Barosi, G
    Alberti, D
    Frassoni, F
    BLOOD, 2001, 98 (11) : 628A - 628A
  • [8] Myelodysplastic syndromes: Defects in expression of genes involved in differentiation and cytoprotection of CD34+cells as detected by oligonuclotide microarrays.
    Hofmann, WK
    de Vos, S
    Hoelzer, D
    Wachsman, W
    Koeffler, HP
    BLOOD, 2001, 98 (11) : 729A - 729A
  • [9] Proteomic Signature of CD34+Cells From Chronic Myeloid Leukemia Patients
    Ricciardi, Maria Rosaria
    Salvestrini, Valentina
    Licchetta, Roberto
    Mirabilii, Simone
    Petrucci, Maria Teresa
    Rossi, Lara
    Allegretti, Matteo
    Salati, Simona
    Castagnetti, Fausto
    Rosti, Gianantonio
    Alimena, Giuliana
    Manfredini, Rossella
    Lemoli, Roberto M.
    Tafuri, Agostino
    BLOOD, 2012, 120 (21)
  • [10] Gene expression profile of peripheral blood CD34+cells from idiopathic myelofibrosis patients
    Vannucchi, AM
    Manfredini, R
    Bianchi, L
    Guglielmelli, P
    Zini, R
    Pancrazzi, A
    Salati, S
    Migliaccio, AR
    Ferrari, S
    Paoletti, F
    EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 59 - 59
12345